The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial
Wendy Y. Chen
Research Funding - Bayer (Inst)
Karla Ballman
Consulting or Advisory Role - Agenus; Medtronic; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Janssen Oncology; Lilly; Sanofi
Eric P. Winer
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - Athenex; Carrick Therapeutics; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Jounce Therapeutics; Leap Therapeutics; Lilly; Seattle Genetics; Syros Pharmaceuticals; Zymeworks
Research Funding - Genentech (Inst)
Other Relationship - InfiniteMD
Thomas H. Openshaw
No Relationships to Disclose
Olwen Mary Hahn
Leadership - Via Oncology
Stock and Other Ownership Interests - Teleflex Medical; Teleflex Medical
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - HMP Global; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
Frederick M. Briccetti
No Relationships to Disclose
William Johnson Irvin
Research Funding - Altor BioScience (Inst); Altor BioScience (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Merck (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seattle Genetics (Inst)
Paula R Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Honoraria - Dava Oncology; Frontiers Media; OncLive/MJH Life Sciences
Consulting or Advisory Role - Bolt Biotherapeutics; Caris Life Sciences; HERON; Immunonet BioSciences; Juniper Pharmaceuticals; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer; Puma Biotechnology; Sirtex Medical
Speakers' Bureau - Genentech/Roche
Research Funding - Advanced Cancer Therapeutics (Inst); Bolt Biotherapeutics (Inst); Byondis (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Cascadian Therapeutics (Inst); Fabre-Kramer (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Pfizer (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Seattle Genetics (Inst); Seattle Genetics (Inst); Seattle Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Patent application; United States Patent no. 8,486,413.; United States Patent no. 8,501,417; United States Patent no. 9,023,362; United States Patent no. 9,745,377
(OPTIONAL) Uncompensated Relationships - Seattle Genetics
Lisa Carey
Research Funding - Abbvie (Inst); NanoString Technologies (Inst); Novartis (Inst); Seattle Genetics (Inst); Syndax (Inst); Veracyte (Inst)
Patents, Royalties, Other Intellectual Property - Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme. (I)
(OPTIONAL) Uncompensated Relationships - Aptitude Health (Inst); AstraZeneca/Daiichi Sankyo (Inst); Eisai; Exact Sciences (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sanofi (Inst)
Ann H. Partridge
Patents, Royalties, Other Intellectual Property - I receive small royalty payments for co-authoring the breast cancer survivorship section of UpToDate
Anna Weiss
No Relationships to Disclose
Linda Mackie McCall
No Relationships to Disclose
Carol Matyka
No Relationships to Disclose
Margaret Carvan
No Relationships to Disclose
Michelle D. Holmes
Research Funding - Bayer (Inst)